US HB8588 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on October 13 2020 - 25% progression, died in committee
Action: 2020-10-13 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 13 2020 - 25% progression, died in committee
Action: 2020-10-13 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.
Title
Improving the American Drug Supply Chain Act of 2020
Sponsors
Rep. Richard Hudson [R-NC] | Rep. Lisa Rochester [D-DE] |
History
Date | Chamber | Action |
---|---|---|
2020-10-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-10-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-10-13 | House | Introduced in House |
Same As/Similar To
HB14 (Related) 2020-11-02 - Referred to the Subcommittee on Railroads, Pipelines, and Hazardous Materials.
Subjects
Congressional oversight
Drug safety, medical device, and laboratory regulation
Economic performance and conditions
Emergency medical services and trauma care
Emergency planning and evacuation
Government studies and investigations
Health
Health care costs and insurance
Health technology, devices, supplies
Intellectual property
Labor market
Manufacturing
Prescription drugs
Drug safety, medical device, and laboratory regulation
Economic performance and conditions
Emergency medical services and trauma care
Emergency planning and evacuation
Government studies and investigations
Health
Health care costs and insurance
Health technology, devices, supplies
Intellectual property
Labor market
Manufacturing
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/8588/all-info |
Text | https://www.congress.gov/116/bills/hr8588/BILLS-116hr8588ih.pdf |